Julien Taieb

Julien Taieb

UNVERIFIED PROFILE

Are you Julien Taieb?   Register this Author

Register author
Julien Taieb

Julien Taieb

Publications by authors named "Julien Taieb"

Are you Julien Taieb?   Register this Author

100Publications

3282Reads

14Profile Views

Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives.

Cancer Treat Rev 2019 May 26;75:1-11. Epub 2019 Feb 26.

Sorbonne Paris-Cité, Paris Descartes University, Hepatogastroenterology and Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, Paris, France; Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.02.002DOI Listing
May 2019

How best to treat older patients with metastatic colorectal cancer?

Authors:
Julien Taieb

Lancet Gastroenterol Hepatol 2019 May 7;4(5):331-333. Epub 2019 Mar 7.

Georges Pompidou European Hospital, Department of Hepatogastroenterology and GI Oncology, Sorbonne Paris Cité/Université Paris Descartes, 75015 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24681253193007
Publisher Site
http://dx.doi.org/10.1016/S2468-1253(19)30076-7DOI Listing
May 2019

Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data.

Stat Methods Med Res 2019 Apr 9:962280219841082. Epub 2019 Apr 9.

1 INSERM U1138, University Paris Descartes, Sorbonne University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0962280219841082DOI Listing
April 2019

[Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?]

Bull Cancer 2019 Feb 4;106(2):129-136. Epub 2018 Dec 4.

European Georges Pompidou Hospital, AP-HP, Department of Gastroenterology and Digestive Oncology, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.10.011DOI Listing
February 2019

How to better select patients with advanced gastric cancer for immunotherapy.

Transl Gastroenterol Hepatol 2019 31;4. Epub 2019 Jan 31.

Department of Gastroenterology and Digestive Oncology, European Georges Pompidou Hospital, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tgh.2019.01.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378262PMC
January 2019

Role of circulating tumor DNA in the management of patients with colorectal cancer.

Clin Res Hepatol Gastroenterol 2018 10 5;42(5):396-402. Epub 2018 Apr 5.

INSERM UMR-S1147, CNRS SNC5014, Paris Descartes University, Equipe labellisée Ligue Nationale contre le cancer, Paris, France; Department of Gastroenterology and Digestive Oncology, European Georges Pompidou Hospital, AP-HP, Paris Descartes University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2018.03.002DOI Listing
October 2018

Beyond Primary Tumor Location and RAS/BRAF Mutational Status as Prognostic Factor in Stage III Colon Cancer-Reply.

Authors:
Julien Taieb

JAMA Oncol 2018 Sep;4(9):1298

Sorbonne Paris Cité, Université Paris Descartes, Department of Gastroenterology and Gastrointestinal Oncology, Hospital Européen Georges Pompidou, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.1718DOI Listing
September 2018

Reply to M. Mo et al.

J Clin Oncol 2018 Aug 4;36(23):2452-2453. Epub 2018 Jun 4.

Thomas Aparicio, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, and Université Paris 7, Sorbonne Paris-Cité, Paris Diderot University, Paris, France; Francois Ghiringhelli, Centre Georges-François Leclerc, Dijon, France; Valerie Boige, Gustave Roussy, Villejuif, France; Karine Le Malicot, Fédération Francophone de Cancérologie Digestive, Dijon, France; Julien Taieb, Sorbonne Paris-Cité, Paris Descartes University, and Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France; and Jaafar Bennouna, Centre Hospitalier Universitaire Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.9669DOI Listing
August 2018

Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.

Br J Cancer 2018 Aug 6;119(4):424-428. Epub 2018 Jun 6.

Department of GI Oncology, Hôpital Européen Georges-Pompidou, APHP, Paris Descartes University, Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0133-7DOI Listing
August 2018

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.

Lancet Oncol 2018 08 2;19(8):1094-1106. Epub 2018 Jul 2.

Department of Oncology, University Hospital of Besancon, Centre Hospitalier Universitaire de Besançon, Besançon, France; Department of Oncology and Radiotherapy, Hôpital Nord Franche Comté, Montbéliard, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France; Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30321-8DOI Listing
August 2018

Trifluridine/tipiracil: an emerging strategy for the management of gastrointestinal cancers.

Future Oncol 2018 Jul 27;14(16):1629-1645. Epub 2018 Apr 27.

Sorbonne Paris Cité, Hôpital Européen Georges Pompidou (HEGP), Paris - Descartes University, Assistance Publique-Hôpitaux de Paris (AP-HP), 75015 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0147DOI Listing
July 2018

5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.

Clin Res Hepatol Gastroenterol 2018 06 7;42(3):255-260. Epub 2017 Dec 7.

Department of gastroenterology and digestive oncology depart, université Paris Descartes, Sorbonne Paris-cité, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22107401173026
Publisher Site
http://dx.doi.org/10.1016/j.clinre.2017.11.004DOI Listing
June 2018

Colorectal Cancer: Why Does Side Matter?

Drugs 2018 Jun;78(8):789-798

Department of Gastroenterology and Digestive Oncology, Assistance Publique-Hôpitaux De Paris, Hôpital Européen Georges Pompidou, Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-018-0921-7DOI Listing
June 2018

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.

J Clin Oncol 2018 May 5;36(15):1469-1477. Epub 2018 Apr 5.

Thierry André and Benoist Chibaudel, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris; Thierry André, Sorbonne Universités, UMPC Paris 06; Marine Hug de Larauze and Benoist Chibaudel and Thierry André, Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR); Christophe Louvet, Institut Mutualiste Montsouris; Céline Lepère, Hôpital Européen Georges Pompidou (HEGP); Gaël Deplanque, Groupe Hospitalier Saint-Joseph; Jean-Baptiste Bachet, Groupe Hospitalier Pitié Salpêtrière and Sorbonne Université, UMPC Paris 06; Ahmed Khalil, Hôpital Tenon; Julien Taieb, Hôpital Européen Georges Pompidou and Sorbonne Paris Cité, Université Paris Descartes, Paris; Julien Taieb, Fédération Française de Cancérologie Digestive; Jeremie Bez, Fédération Française de Cancérologie Digestive; François Ghiringhelli, Centre Georges-François Leclerc, Dijon; Dewi Vernerey and Sophie Paget-Bailly, CHU de Besançon; Serge Fratte, Hôpital de Besançon; Sophie Paget-Bailly, Franck Bonnetain and Dewi Vernerey INSERM UMR1098, Besançon; Laurent Mineur, Institut Sainte Catherine, Avignon; Jaafar Bennouna, Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain et Institut de Cancérologie Paul Papin, Angers; Jérôme Desrame, Hôpital Jean Mermoz, Lyon; Roger Faroux, Centre Hospitalier Départemental de La Roche sur Yon, La Roche sur Yon; Serge Fratte, Hôpital of Belfort-Montbeliard, Montbeliard; Jérôme Dauba, Centre Hospitalier Layné, Mont-de-Marsan; Olivier Dupuis, Clinique Victor Hugo, Le Mans; Yves Becouran, Institut Bergonié, Bordeaux; May Mabro, Hôpital Foch, Suresnes; Joëlle Egreteau, Centre Hospitalier de Bretagne Sud Site de Lorient, Lorient; Olivier Bouche, Hôpital Robert Debré, Reims; Marc Ychou, Institut du Cancer de Montpellier, and CHU de Montpellier, Montpellier; Marie Pierre Galais, Centre Francois Baclesse, Caen; Louis Marie Dourthe, Clinique Sainte Anne, Strasbourg; and Aimery de Gramont, Institut Hospitalier Franco-Britannique, Levallois-Perret, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.0355
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.0355DOI Listing
May 2018

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.

Cancer Treat Rev 2018 May 22;66:104-113. Epub 2018 Apr 22.

Seoul National University College of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.04.004DOI Listing
May 2018

Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9).

J Clin Oncol 2018 03 18;36(7):674-681. Epub 2018 Jan 18.

Thomas Aparicio, Centre Hospitalier Universitaire (CHU) Saint Louis, Assistance Public Hôpitaux de Paris (APHP), and Université Paris 7, Sorbonne Paris Cité; Julien Taieb, Hôpital Européen Georges Pompidou, Paris; Francois Ghiringhelli, Centre Georges-François Leclerc; Karine Le Malicot, Fédération Francophone de Cancérologie Digestive; Come Lepage, CHU Le Bocage, Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche (UMR) 1231, Dijon; Valérie Boige, Institut Gustave Roussy, Villejuif; Olivier Bouché, CHU Robert Debré, Reims; Jean-Marc Phelip, CHU Saint Etienne-Hôpital Nord, Saint Priest en Jarez; Eric François, Centre Antoine Lacassagne, Nice; Christian Borel, Paul Strauss Center, Strasbourg; Roger Faroux, Centre Hospitalier (CH) La Roche sur Yon, La Roche sur Yon; Laetitia Dahan, CHU La Timone, Aix-Marseille-University, Marseille; Stéphane Jacquot, Centre de Cancérologie du Grand Montpellier, Montpellier; Dominique Genet, Accompagnement de la Recherche Clinique Hospitalière (ARCH)/Polyclinique, Limoges; Faiza Khemissa, CH Saint Jean, Perpignan; Etienne Suc, Clinique Saint Jean du Languedoc, Toulouse; Françoise Desseigne, Centre Léon Bérard, Lyon; Patrick Texereau, CH Layne, Mont-De-Marsan; and Jaafar Bennouna, Institut de Cancérologie de l'Ouest, Saint Herblay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.2931DOI Listing
March 2018

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

N Engl J Med 2018 Mar;378(13):1177-1188

From the Divisions of Medical Oncology (A.G.) and Biomedical Statistics and Informatics (Q.S., J.P.M., L.A.R., D.J.S.), Mayo Clinic, Rochester, MN; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST, Genoa (A.F. Sobrero), Ospedale Papa Giovanni XXIII, Bergamo (R.L.), and IRCCS Mario Negri Institute for Pharmacological Research, Milan (V.T.) - all in Italy; Karmanos Cancer Institute, Wayne State University, Detroit (A.F. Shields); National Cancer Center Hospital East, Chiba (T. Yoshino), Yokohama City University School of Medicine, Yokohama (T. Yamanaka), and the University of Tokyo, Tokyo (T.W.) - all in Japan; the Institute of Cancer Sciences, University of Glasgow, Glasgow (J.P.), the University of Oxford, Oxford (R.K.), Christie Hospital, Manchester (M.S.), and University Hospital Southampton, Southampton (T.I.) - all in the United Kingdom; Hôpital Européen Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University (J.T.), and Saint-Antoine Hospital and Sorbonne Universités, Pierre and Marie Curie University-Paris 6 (T.A.), Paris, and Methodology and Quality of Life Unit, INSERM Unité 1098, Besançon (D.V.) - all in France; the Department of Medical Oncology, University Hospital of Heraklion, Faculty of Medicine, University of Crete, Heraklion (J.S.), and Bioclinic Thessaloniki, Thessaloniki (I.B.) - both in Greece; Dana-Farber Cancer Institute, Boston (J.A.M.); and Duke Cancer Institute, Durham, NC (D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1713709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426127PMC
March 2018

Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study.

Target Oncol 2018 02;13(1):107-112

Department of Gastroenterology and Digestive Oncology, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, 20 rue Leblanc, 75015, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0531-4DOI Listing
February 2018

Adequate SIRT activity dose is as important as adequate chemotherapy dose - Authors' reply.

Lancet Oncol 2017 11 31;18(11):e637. Epub 2017 Oct 31.

Imperial College Healthcare NHS Trust & Imperial College, Hammersmith Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30801-XDOI Listing
November 2017

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study).

Clin Cancer Res 2017 Sep 2;23(18):5416-5425. Epub 2017 Jun 2.

INSERM UMR-S1147, CNRS SNC5014; Paris Descartes University, Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-3155DOI Listing
September 2017

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Lancet Oncol 2017 09 3;18(9):1159-1171. Epub 2017 Aug 3.

Cancer Research UK Medical Research Council (CRUK-MRC) Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre, UCL Cancer Institute, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30457-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593813PMC
September 2017

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).

Br J Cancer 2017 Sep 17;117(7):965-973. Epub 2017 Aug 17.

INSERM, UMRS 935 Team 'Cancer Chronotherapy and Postoperative Liver Function', Campus CNRS, 7 rue Guy Môquet, and UMRS 1193 'Physiopathology and treatment of Liver diseases', Paul Brousse Hospital, 14 avenue Paul-Vaillant-Couturier, 94800 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625679PMC
September 2017

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.

Eur J Cancer 2017 07 26;79:15-22. Epub 2017 Apr 26.

INSERM U970 - PARCC (Paris Cardiovascular Research Center), Paris Descartes University, Sorbonne Paris Cité, Paris, France; Hôpital Européen Georges-Pompidou, APHP, Department of GI Oncology, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.03.036DOI Listing
July 2017

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

J Natl Cancer Inst 2017 05 31;109(5). Epub 2016 Dec 31.

Affiliations of authors: Department of Gastroenterology and GI Oncology, Université Paris Descartes, Hopital Européen Georges Pompidou, Paris, France (JTai); Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France (KLM); Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (QS, DJS); Department of Pathology, Centre Jean Perrin, EA ERTICa, Université d'Auvergne, Clermont-Ferrand, France (FPL); Centre Hospitalier Universitaire Robert Debré, Reims, France (OB); Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain (JTab); Spanish Gastrointestinal Tumors TTD Group, Universitat Autònoma de Barcelona, Barcelona, Spain (JTab); Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy (EM); Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG); First Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany (GF); Department of Gastroenterology, Hôpital Universitaire Erasme, Brussels, Belgium (JLVL); Department of Oncology, Mayo Clinic and Mayo Cancer Center, Rochester, MN (SRA, FAS); Pathology Department, Ambroise Paré Hospital, Boulogne, France (JFE); Université Paris Descartes, Sorbonne Paris Cité, France (PLP); Assistance Publique Hôpitaux de Paris, Department of Biology, Hôpital Européen Georges Pompidou, Paris, France (PLP); INSERM UMR-S1147, Paris, France (PLP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075212PMC
May 2017

Unresectable liver metastases in colorectal cancer: review of current strategies.

Minerva Chir 2016 Dec 12;71(6):382-397. Epub 2016 Oct 12.

Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Descartes University, Paris, France -

View Article

Download full-text PDF

Source
December 2016

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

Eur J Cancer 2016 11 18;68:163-172. Epub 2016 Oct 18.

AP-HP, Departments of Medical Oncology, Hepato-Biliary Surgery and Radiology, Paul Brousse Hospital, Villejuif, France; INSERM and Paris-Saclay UMR S935, CNRS Campus, Villejuif, France; Cancer Chronotherapy Unit, Warwick Medical School, Coventry, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.09.011DOI Listing
November 2016

Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practice.

Clin Res Hepatol Gastroenterol 2016 Nov 2;40(5):546-552. Epub 2016 May 2.

Université Paris Descartes, Department of Hepatogastroenterology and GI Oncology, hôpital européen Georges-Pompidou, 75015 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2016.03.004DOI Listing
November 2016

[Quality of life during and after therapy].

Authors:
Julien Taieb

Bull Acad Natl Med 2015 Feb-Mar;199(2-3):223-9

View Article

Download full-text PDF

Source
September 2016

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer.

Clin Colorectal Cancer 2016 09 2;15(3):250-6. Epub 2015 Dec 2.

Multidisciplinary Oncology Research Group (Groupe Coopérateur Multidisciplinaire en Oncologie), Paris, France; Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France; Université Pierre et Marie Curie Paris 6, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.11.004DOI Listing
September 2016

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.

J Natl Cancer Inst 2016 Jul 1;108(7). Epub 2016 Feb 1.

Affiliations of authors: Department of Gastroenterology (DT, GS, CS), Department of Medical Oncology (AF), and Department of Molecular Oncology (LKT), Poitiers University Hospital , Poitiers , France ; Laboratoire Inflammation, Tissus Epithéliaux et Cytokines (LITEC) - EA 4331, Poitiers University , Poitiers (DT, CS); Methodology and Quality of Life in Oncology Unit, Besançon University Hospital , Besançon , France (GM); Department of Gastroenterology, Ambroise Paré Hospital , Boulogne-Billancourt , France (IT); Department of Gastroenterology (TL) and Department of Biochemistry (JCP), Tours University Hospital , Tours , France , UMR GICC CNRS 7292, Tours François Rabelais University, Tours (TL); Paris Descartes University, Cochin Hospital , Paris , France (RC); Department of Gastroenterology (TA) and Department of Medical Oncology (CDG), Avicenne Hospital , Bobigny , France ; Department of Gastroenterology, Bordeaux Nord Aquitaine Clinic , Bordeaux , France (CL); Department of Gastroenterology, Jean Mermoz Lyon Hospital , Lyon , France (PA); Department of Gastroenterology, Nantes University Hospital , Nantes , France (EC, TMB); Department of Gastroenterology, Rouen University Hospital , Rouen , France (DS, PM); Department of Medical Oncology, Saint-Antoine Hospital , Paris , France (TB); Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, APHP , Paris , France (JT, AZ); Paris Descartes University, Sorbonne Paris Cité , Paris , France (RC, JT, AZ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv438DOI Listing
July 2016

Checkpoint inhibitors and gastrointestinal immune-related adverse events.

Curr Opin Oncol 2016 07;28(4):264-8

Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Descartes University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000292DOI Listing
July 2016

Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.

JAMA Oncol 2016 May;2(5):643-653

Centre de Recherché UMR-S 1147, Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique, Institut National de la Santé et de la Recherche Médicale, Paris, France6Paris Descartes University, Department of Biology, European Georges Pompidou Ho.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.5225DOI Listing
May 2016

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.

J Clin Oncol 2016 05 22;34(15):1723-31. Epub 2016 Feb 22.

Guy A. van Hazel, University of Western Australia; Tom Ferguson, Royal Perth Hospital; David Price and Geoff Bower, Mount Medical Center, Perth; Alex Powell, Hollywood Private Hospital, Nedlands, Western Australia; Andrew H. Strickland, Monash Medical Centre, Bentleigh, East Victoria; Vinod Ganju, Frankston Private Hospital Peninsula Oncology Centre, Frankston; Peter Gibbs, Western Hospital, Footscray, Victoria; Euan Walpole, Princess Alexandra Hospital, Woolloongabba; Paul Eliadis, Wesley Medical Centre, Milton, Queensland; Val Gebski, NHMRC Clinical Trials Centre, Camperdown; David N. Cade and Kenneth Thurston, Sirtex Medical Limited, North Sydney, New South Wales, Australia; Volker Heinemann, Ludwig-Maximilian-University of Munich, Munich; Jens Ricke, University Clinic Magdeburg; Hendrik Kroening, Schwerpunktpraxis of Haematology and Oncology, Magdeburg, Germany; Navesh K. Sharma, University of Maryland Medical Center; Fred Moeslein, University of Maryland School of Medicine, Baltimore, MD; Mark Van Buskirk, Data Reduction LLC, Chester, NJ; Michael P.N. Findlay, Cancer Trials New Zealand, Auckland; David Perez, Dunedin Hospital, Dunedin; Bridget A. Robinson, Christchurch Hospital, Christchurch; Richard Isaacs, Palmerston North Hospital, Palmerston, New Zealand; Marc Peeters, Antwerp University Hospital, Antwerp, Belgium; Javier Rodríguez, Clinica Universidad de Navarra, Pamplona, Spain; Ido Wolf and Einat Shacham-Shmueli, Sheba Medical Center, Tel-Hashomer; Thomas Tichler, Shaare-Zedek Medical Center, Jerusalem, Israel; Eveline Boucher, Hopital de Jour, Rennes; and Julien Taieb, Georges Pompidou European Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.1181DOI Listing
May 2016

Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'.

Br J Cancer 2016 05 28;114(11):e9. Epub 2016 Apr 28.

Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Descartes University, Paris 75015, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.70DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891508PMC
May 2016

Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.

Clin Res Hepatol Gastroenterol 2016 Apr 4;40(2):154-60. Epub 2015 Nov 4.

Department of Gastroenterology and Digestive Oncology, European Georges Pompidou Hospital, AP-HP, 20, rue Leblanc, 75015 Paris, France; UMR-S 1147, Inserm, Paris, France; Paris Descartes University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2015.09.008DOI Listing
April 2016

Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.

Dig Liver Dis 2016 Apr 29;48(4):441-5. Epub 2015 Dec 29.

Paris Descartes University, Sorbonne Paris Cité, Faculty of Medicine, Paris, France; Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, APHP, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2015.12.012DOI Listing
April 2016

Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.

World J Gastroenterol 2015 Oct;21(40):11428-38

Simon Pernot, Geraldine Perkins, Julien Taieb, Department of Gastroenterology and Digestive Oncology, Georges-Pompidou European Hospital, Paris Descartes, Sorbonne Paris Cité, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i40.11428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616218PMC
October 2015

[Adjuvant treatment for resected colon cancer].

Rev Prat 2015 Jun;65(6):789-92

View Article

Download full-text PDF

Source
June 2015

[Impact of VEGF-A in exhaustion of intratumoral T cells].

Med Sci (Paris) 2015 May 9;31(5):473-5. Epub 2015 Jun 9.

Inserm U970, PARCC (Paris cardiovascular research center), Université Paris-Descartes, Sorbonne Paris Cité, 56, rue Leblanc, 75015 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20153105004DOI Listing
May 2015

Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer.

Nutr Cancer 2014 7;66(4):583-9. Epub 2014 Apr 7.

a Service de Gastro-entérologie et Endoscopie Digestive, Hôpital Européen Georges Pompidou, Paris, France; Association des Gastroentérologues Oncologues, France; Assistance-publique Hôpitaux de Paris, Paris, France, and Université Paris-Descartes, Sorbonne Paris-Cité , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2014.894103DOI Listing
December 2014

Case histories in unresectable liver-dominant metastatic colorectal cancer.

Future Oncol 2014 Nov;10(15 Suppl):41-7

CRUK-MRC Oxford Institute for Radiation Oncology, Department of Oncology, Old Road Campus Research Building, University of Oxford, Oxford, OX3 7DQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.222DOI Listing
November 2014

Control of the immune response by pro-angiogenic factors.

Front Oncol 2014 2;4:70. Epub 2014 Apr 2.

INSERM U970, PARCC (Paris Cardiovascular Research Center), Université Paris-Descartes, Sorbonne Paris Cité , Paris , France.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fonc.2014.000
Publisher Site
http://dx.doi.org/10.3389/fonc.2014.00070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980099PMC
June 2014

[Sarcopenia: a concept of growing importance in the management of colorectal cancer].

Presse Med 2014 Jun 21;43(6 Pt 1):628-32. Epub 2014 May 21.

Faculté Paris Descartes, 75006 Paris, France; Hôpital Européen Georges-Pompidou, service d'hépato-gastro-entérologie et oncologie digestive, 75015 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2013.12.021DOI Listing
June 2014

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy.

Clin Res Hepatol Gastroenterol 2014 Apr 18;38(2):e23-6. Epub 2014 Feb 18.

Service d'hépatogastro-entérologie et d'oncologie digestive, université Paris Descartes, Sorbonne Paris-Cité, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2014.01.005DOI Listing
April 2014

Colorectal cancer and immunity: what we know and perspectives.

World J Gastroenterol 2014 Apr;20(14):3738-50

Simon Pernot, Orianne Colussi, Julien Taieb, Service d'Hépatogastro-entérologie et d'oncologie digestive, Hôpital Européen Georges-Pompidou, Université Paris Descartes, Sorbonne Paris Cité, 75015 Paris, France.

View Article

Download full-text PDF

Source
http://www.wjgnet.com/esps/DownLoadFile.aspx?Type=Digital&Su
Web Search
http://www.wjgnet.com/1007-9327/full/v20/i14/3738.htm
Publisher Site
http://dx.doi.org/10.3748/wjg.v20.i14.3738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983433PMC
April 2014

Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspects.

Clin Res Hepatol Gastroenterol 2014 Feb 8;38(1):18-23. Epub 2013 Aug 8.

Service d'Hépatogastro-entérologie et d'oncologie digestive, Hôpital Européen Georges-Pompidou, Université Paris Descartes, 20, rue Leblanc, 75015 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2013.07.002DOI Listing
February 2014

[MET signalling pathway and its therapeutic implications in gastrointestinal cancers].

Bull Cancer 2014 Jan;101(1):25-30

Hôpital européen Georges-Pompidou, AP-HP, Service de gastroentérologie et oncologie digestive, 20, rue Leblanc, 75015 Paris, France.

View Article

Download full-text PDF

Source
http://www.john-libbey-eurotext.fr/medline.md?doi=10.1684/bd
Publisher Site
http://dx.doi.org/10.1684/bdc.2013.1870DOI Listing
January 2014

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer.

Oncoimmunology 2013 Aug 10;2(8):e25156. Epub 2013 Jun 10.

INSERM U970; PARCC (Paris Cardiovascular Research Center); Université Paris-Descartes; Sorbonne Paris Cité; Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.25156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782524PMC
August 2013